about
Circulating tumor cells predict survival in early average-to-high risk breast cancer patients.Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system.Misfolded proteins: from little villains to little helpers in the fight against cancer.Prevalence of CA 27.29 in primary breast cancer patients before the start of systemic treatment.Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer.
P50
description
onderzoeker
@nl
name
Julia Jückstock
@ast
Julia Jückstock
@en
Julia Jückstock
@es
Julia Jückstock
@sl
type
label
Julia Jückstock
@ast
Julia Jückstock
@en
Julia Jückstock
@es
Julia Jückstock
@sl
prefLabel
Julia Jückstock
@ast
Julia Jückstock
@en
Julia Jückstock
@es
Julia Jückstock
@sl